Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-dependent calcium channels (VDCCs) in smooth muscle cells, primarily the L-type (Cav1.2) isoform, are critical regulators of muscle tone and vascular resistance [3, 7]. These channels open in response to membrane depolarization, allowing an influx of extracellular calcium ions that triggers the contraction of smooth muscle through the activation of calmodulin and myosin light-chain kinase [8, 10]. In the vasculature, this process is essential for maintaining blood pressure and regulating blood flow to various organs [17]. Dysregulation of these channels is a key factor in the pathogenesis of hypertension and vasospastic disorders [16]. Consequently, they are the primary targets for calcium channel blockers (CCBs), which are widely used to treat cardiovascular conditions by inducing vasodilation and reducing systemic vascular resistance [4, 15]. These drugs are categorized into dihydropyridines, which are selective for vascular smooth muscle, and non-dihydropyridines, which also affect cardiac conduction and contractility [14].
Inhibition of calcium ion influx through the L-type voltage-gated calcium channel pore, leading to a decrease in intracellular calcium concentration and subsequent relaxation of smooth muscle cells (vasodilation) [4, 14].
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-gated L-type calcium channel subunit alpha-1C (Cav1.2).